Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update

Neil K. Warma, president and chief executive officer of Opexa. “The Novartis stem cell transaction bolstered our financial resources and consequently leaves us with $4.1 million in cash as of the end of October. Third Quarter... [read full story]                    

powered by
Add Comment
There are also 3 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies